Clinical Trials for ABL Bio

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ABL Bio

Clinical Trials (3)

NCT07158918
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
65 participants
Started: Aug 6, 2025 · Completed: Dec 2, 2027
1 condition2 sponsors6 locations
NCT06126666
A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
96 participants
Started: Nov 7, 2023 · Completed: Nov 15, 2027
1 condition1 sponsor3 locations
NCT04762641
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
100 participants
Started: Apr 1, 2021 · Completed: Jun 15, 2026
1 condition1 sponsor8 locations